These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33370245)

  • 1. Cost Effectiveness of Fish Skin Grafts Versus Standard of Care on Wound Healing of Chronic Diabetic Foot Ulcers: A Retrospective Comparative Cohort Study.
    Winters C; Kirsner RS; Margolis DJ; Lantis JC
    Wounds; 2020 Oct; 32(10):283-290. PubMed ID: 33370245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective.
    Su HY; Yang CY; Ou HT; Chen SG; Chen JC; Ho HJ; Kuo S
    JAMA Netw Open; 2023 Jan; 6(1):e2250639. PubMed ID: 36633847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin Substitutes for Adults With Diabetic Foot Ulcers and Venous Leg Ulcers: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(7):1-165. PubMed ID: 34211616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cost-Effectiveness Analysis Comparing Single-use and Traditional Negative Pressure Wound Therapy to Treat Chronic Venous and Diabetic Foot Ulcers.
    Kirsner RS; Delhougne G; Searle RJ
    Wound Manag Prev; 2020 Mar; 66(3):30-36. PubMed ID: 32294054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A purified reconstituted bilayer matrix shows improved outcomes in treatment of non-healing diabetic foot ulcers when compared to the standard of care: Final results and analysis of a prospective, randomized, controlled, multi-centre clinical trial.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; DiDomenico LA; Zelen CM
    Int Wound J; 2024 Apr; 21(4):e14882. PubMed ID: 38606794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multicenter, Blinded, Randomized Controlled Clinical Trial Evaluating the Effect of Omega-3-Rich Fish Skin in the Treatment of Chronic, Nonresponsive Diabetic Foot Ulcers.
    Lullove EJ; Liden B; Winters C; McEneaney P; Raphael A; Lantis Ii JC
    Wounds; 2021 Jul; 33(7):169-177. PubMed ID: 33872197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention processed placental membrane versus standard of care in treating diabetic foot ulcers.
    Frykberg RG; Tunyiswa Z; Weston WW
    Int Wound J; 2024 Oct; 21(10):e70096. PubMed ID: 39402007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydrated human amnion and chorion allograft versus standard of care alone in treatment of Wagner 1 diabetic foot ulcers: a trial-based health economics study.
    Carter MJ
    J Med Econ; 2020 Nov; 23(11):1273-1283. PubMed ID: 32729342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faster Than Projected Healing in Chronic Venous and Diabetic Foot Ulcers When Treated with Intact Fish Skin Grafts Compared to Expected Healing Times for Standard of Care: An Outcome-Based Model from a Swiss Hospital.
    Zehnder T; Blatti M
    Int J Low Extrem Wounds; 2022 May; ():15347346221096205. PubMed ID: 35546101
    [No Abstract]   [Full Text] [Related]  

  • 11. Wound Conforming Matrix Containing Purified Homogenate of Dermal Collagen Promotes Healing of Diabetic Neuropathic Foot Ulcers: Comparative Analysis Versus Standard of Care.
    Chandler LA; Alvarez OM; Blume PA; Kim PJ; Kirsner RS; Lantis JC; Marston WA
    Adv Wound Care (New Rochelle); 2020 Feb; 9(2):61-67. PubMed ID: 31903299
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
    Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
    J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health economics for treatment of diabetic foot ulcers: a cost-effectiveness analysis of eight skin substitutes.
    Samsell B; McLean J; Cazzell S; Dorsch K; Moyer PM; Moore M
    J Wound Care; 2019 Sep; 28(Sup9):S14-S26. PubMed ID: 31509489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
    Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
    Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential cost-effectiveness of using a collagen-containing dressing in managing diabetic foot ulcers in the UK.
    Guest JF; Singh H; Vowden P
    J Wound Care; 2018 Mar; 27(3):136-144. PubMed ID: 29509110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperbaric Oxygen Therapy for the Treatment of Diabetic Foot Ulcers: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(5):1-142. PubMed ID: 28572866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers improves patient outcomes vs standard of care: Results of a prospective randomised controlled multi-centre clinical trial.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; DiDomenico LA; Zelen CM
    Int Wound J; 2022 Aug; 19(5):1197-1209. PubMed ID: 35001559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Evaluation of Sucrose Octasulfate Dressing for Treatment of Diabetic Foot Ulcers in Patients with Type 2 Diabetes.
    Wen J; Jin X; Al Sayah F; Johnson JA; Paulden M; Ohinmaa A
    Can J Diabetes; 2022 Mar; 46(2):126-133. PubMed ID: 35148951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acellular Fish Skin Graft Use for Diabetic Lower Extremity Wound Healing: A Retrospective Study of 58 Ulcerations and a Literature Review.
    Michael S; Winters C; Khan M
    Wounds; 2019 Oct; 31(10):262-268. PubMed ID: 31730505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.
    Kaur R; Tchanque-Fossuo C; West K; Hadian Y; Gallegos A; Yoon D; Ismailyan L; Schaefer S; Dahle SE; Isseroff RR
    Trials; 2020 Jun; 21(1):496. PubMed ID: 32513257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.